Objective Gastric cancer is the second leading cause of cancer-related deaths and the fifth most common malignancy worldwide.Gastric cancer(GC)is a common malignancy with low 5-year overall survival(O
Objective Bisphosphonates are commonly administered as bone-specific anti-resorptive agents to patients who at increased risk of developing osteoporosis,multiple myeloma(MM),Pagets disease,and bone me